We are live on ! Find out more
FA

Friess Associates Portfolio holdings

AUM $59.9M
1-Year Est. Return 3.42%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+3.42%
3 Year Est. Return
+255.77%
5 Year Est. Return
+639.06%
10 Year Est. Return
AUM
$1.37B
AUM Growth
+$7.21M
Cap. Flow
-$80.1M
Cap. Flow %
-5.84%
Top 10 Hldgs %
22.21%
Holding
150
New
33
Increased
35
Reduced
24
Closed
34

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$24.1M
2
EA icon
Electronic Arts
EA
+$19.5M
3
K
Kellanova
K
+$19.5M
4
TSN icon
Tyson Foods
TSN
+$17.7M
5
YETI icon
Yeti Holdings
YETI
+$17.4M

Sector Composition

Rank Sector Weight
1 Technology 26.85%
2 Consumer Discretionary 16.84%
3 Healthcare 13.99%
4 Industrials 13.15%
5 Communication Services 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSSC icon
76
Napco Security Technologies
NSSC
$1.36B
$5.39M 0.39%
+363,298
New +$4.82M
CYRX icon
77
CryoPort
CYRX
$772M
$5.31M 0.39%
+290,000
New +$4.6M
VAPO
78
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$5.03M 0.37%
27,320
-1,624
-6% -$240K
GLUU
79
DELISTED
Glu Mobile Inc.
GLUU
$5.02M 0.37%
699,788
+65,415
+10% +$601K
CROX icon
80
Crocs
CROX
$6.49B
$4.78M 0.35%
242,235
+3,216
+1% +$74.5K
EVOP
81
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$4.72M 0.34%
+149,848
New +$4.37M
MINI
82
DELISTED
Mobile Mini Inc
MINI
$4.66M 0.34%
153,091
-187,437
-55% -$6.22M
CENT icon
83
Central Garden & Pet Co
CENT
$2.72B
$4.65M 0.34%
+215,788
New +$4.76M
EGIO
84
DELISTED
Edgio, Inc. Common Stock
EGIO
$4.27M 0.31%
39,504
+36,937
+1,439% +$4.41M
ESTA icon
85
Establishment Labs
ESTA
$2.74B
$4.26M 0.31%
193,625
+16,439
+9% +$393K
RCM
86
DELISTED
R1 RCM Inc. Common Stock
RCM
$4.05M 0.3%
+322,000
New +$3.64M
HURN icon
87
Huron Consulting
HURN
$2.41B
$4.05M 0.3%
80,369
+2,143
+3% +$105K
APPS icon
88
Digital Turbine
APPS
$1.07B
$3.85M 0.28%
+770,500
New +$3.1M
NOG icon
89
Northern Oil and Gas
NOG
$2.24B
$3.8M 0.28%
197,019
-1,520
-0.8% -$35.1K
HEES
90
DELISTED
H&E Equipment Services
HEES
$3.78M 0.28%
+130,000
New +$3.62M
VCYT icon
91
Veracyte
VCYT
$3.62B
$3.73M 0.27%
130,856
-25,550
-16% -$638K
LOVE
92
DELISTED
LoveSac
LOVE
$3.58M 0.26%
115,394
+52,000
+82% +$1.79M
NVS icon
93
Novartis
NVS
$292B
$3.58M 0.26%
+39,235
New +$3.32M
ZUMZ icon
94
Zumiez
ZUMZ
$344M
$3.42M 0.25%
+130,836
New +$3.18M
ELAN icon
95
Elanco Animal Health
ELAN
$12.7B
$3.16M 0.23%
93,498
-500,000
-84% -$16.2M
EVER icon
96
EverQuote
EVER
$887M
$2.87M 0.21%
220,859
+5,293
+2% +$55K
ZM icon
97
Zoom
ZM
$28.9B
$2.73M 0.2%
+30,729
New +$2.53M
ITGR icon
98
Integer Holdings
ITGR
$4.23B
$2.4M 0.18%
+28,600
New +$2.14M
LAB icon
99
Standard BioTools
LAB
$342M
$2.38M 0.17%
+193,100
New +$2.46M
CLAR icon
100
Clarus
CLAR
$127M
$2.24M 0.16%
156,005

Similar funds

Friess Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Friess Associates held 150 positions worth $1.37B, up 0.53% from $1.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Friess Associates withdrew a net $80.1M in Q2 2019, closing 34 positions and reducing 24 holdings. Its most notable exit was Salesforce, an estimated $29.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Friess Associates opened a new position in Advanced Micro Devices worth $25.7M.

  • Friess Associates's largest Q2 2019 buy was Advanced Micro Devices: 846,361 shares worth $25.7M.
  • Friess Associates added most to Lyft in Q2 2019, an estimated $7.73M increase.
  • Friess Associates's biggest Q2 2019 reduction was Elanco Animal Health, cutting an estimated $16.2M.
  • Friess Associates fully exited Salesforce in Q2 2019, selling an estimated $29.8M.
  • Friess Associates's ten largest holdings make up 22% of its $1.37B portfolio in Q2 2019.
  • Friess Associates opened 33 new positions and closed 34 in Q2 2019.
  • Friess Associates's portfolio value rose 0.53% quarter-over-quarter to $1.37B.

Based on Friess Associates's 13F filing for Q2 2019, filed 14 Aug 2019.